BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27160965)

  • 1. The safety of isotretinoin in patients with lupus nephritis: a comprehensive review.
    Miziołek B; Bergler-Czop B; Stańkowska A; Brzezińska-Wcisło L
    Cutan Ocul Toxicol; 2017 Mar; 36(1):77-84. PubMed ID: 27160965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory effects of isotretinoin in patients with acne.
    Karadag AS; Ertugrul DT; Bilgili SG; Takci Z; Akin KO; Calka O
    Br J Dermatol; 2012 Aug; 167(2):433-5. PubMed ID: 22435970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
    Liao R; Liu Q; Zheng Z; Fan J; Peng W; Kong Q; He H; Yang S; Chen W; Tang X; Yu X
    PLoS One; 2015; 10(7):e0132724. PubMed ID: 26161538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the efficacy and safety of a combination of 2 topical retinoids (RetinSphere) in maintaining post-treatment response of acne to oral isotretinoin.
    Truchuelo MT; Jiménez N; Mavura D; Jaén P
    Actas Dermosifiliogr; 2015 Mar; 106(2):126-32. PubMed ID: 25306870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric disorders, acne and systemic retinoids: comparison of risks.
    Le Moigne M; Bulteau S; Grall-Bronnec M; Gerardin M; Fournier JP; Jonville-Bera AP; Jolliet P; Dreno B; Victorri-Vigneau C
    Expert Opin Drug Saf; 2017 Sep; 16(9):989-995. PubMed ID: 28657366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoids and sebaceous gland activity.
    Geiger JM
    Dermatology; 1995; 191(4):305-10. PubMed ID: 8573927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatological indications for the use of isotretinoin beyond acne.
    Forbat E; Ali FR; Al-Niaimi F
    J Dermatolog Treat; 2018 Nov; 29(7):698-705. PubMed ID: 29480033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of systemic agents in the treatment of acne vulgaris.
    Johnson BA; Nunley JR
    Am Fam Physician; 2000 Oct; 62(8):1823-30, 1835-6. PubMed ID: 11057839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
    dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
    Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.
    Cheng CC; Lee YF; Lan JL; Wu MJ; Hsieh TY; Lin NN; Wang JM; Chiu YT
    Lupus; 2013 May; 22(6):554-61. PubMed ID: 23478030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral 9-cis-retinoic acid versus 13-cis-retinoic acid in acne therapy.
    Ott F; Bollag W; Geiger JM
    Dermatology; 1996; 193(2):124-6. PubMed ID: 8884148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uses and complications of isotretinoin therapy.
    Ellis CN; Krach KJ
    J Am Acad Dermatol; 2001 Nov; 45(5):S150-7. PubMed ID: 11606947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin therapy for the treatment of acne in patients with cystic fibrosis: a case series and review of the literature.
    Bari O; Paravar T
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eruptive milia during isotretinoin therapy.
    Farmer W; Cheng K; Marathe K
    Pediatr Dermatol; 2017 Nov; 34(6):728-729. PubMed ID: 28940619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids and glomerular regeneration.
    Lazzeri E; Peired AJ; Lasagni L; Romagnani P
    Semin Nephrol; 2014 Jul; 34(4):429-36. PubMed ID: 25217271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol.
    Grønhøj Larsen F; Jakobsen P; Grønhøj Larsen C; Heidenheim M; Held E; Nielsen-Kudsk F
    Br J Dermatol; 2009 Sep; 161(3):664-70. PubMed ID: 19563582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune podocytes in the immune microenvironment of lupus nephritis (Review).
    Liu R; Wen X; Peng X; Zhao M; Mi L; Lei J; Xu K
    Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
    Yuan M; Tan Y; Wang Y; Wang SX; Yu F; Zhao MH
    Lupus; 2019 Mar; 28(3):347-358. PubMed ID: 30755145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acne infantum successfully treated with isotretinoin.
    Torrelo A; Pastor MA; Zambrano A
    Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study.
    Erturan İ; Naziroğlu M; Akkaya VB
    Cell Biochem Funct; 2012 Oct; 30(7):552-7. PubMed ID: 22517509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.